Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    AEON Biopharma, Inc. (AEON) Insider Trading Activity

    Healthcare • Biotechnology • 5 employees

    AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. The company is based in Irvine, California.

    Total Value

    $30,000.00

    Total Shares

    1,005,013

    Average Trade Value

    $3,750.00

    Most Active Insider

    Carter Eric G

    Total Activity: $10,000

    Largest Single Transaction

    $10,000

    by Carter Eric G on Aug 31, 2024

    30-Day Activity

    0 Transactions

    Volume: 0 shares
    Value: $0

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Exec Vp, Clo Corp Secretary
    Officer
    Aug 31, 2024 180,110 $0 261,538 (+68.9%) Grant
    Director
    Aug 31, 2024 36,021 $0 96,785 (+37.2%) Grant
    Principal Accounting Officer
    Officer
    Aug 31, 2024 18,010 $0 18,010 (+100.0%) Grant
    Chief Medical Officer
    Officer
    Aug 31, 2024 192,117 $0 292,545 (+65.7%) Grant
    Director
    Aug 31, 2024 36,021 $10,000 36,021 (+100.0%) Grant
    Chief Exectuive Officer
    Director, Officer
    Aug 31, 2024 470,692 $0 750,547 (+62.7%) Grant
    Director
    Aug 31, 2024 36,021 $10,000 36,021 (+100.0%) Grant
    Director
    Aug 31, 2024 36,021 $10,000 36,021 (+100.0%) Grant